Psychedelic Therapy Realities

Stephen highlights the importance of quality control in psychedelic therapy, cautioning against problematic practitioners. He sheds light on challenges in running clinical trials with drugs like MDMA and psilocybin, emphasizing the difficulty in accurately assessing their effectiveness due to blinding issues.